Concepedia
Statistics
Publications
4
Citations
284
H-Index
Active since
2004
Affiliations
National Cancer Institute(Current)
Molecular Oncology (United States)
Science Applications International Corporation (United States)
Donna J. Carter is an author at National Cancer Institute specializing in cell biology, engineering, and dna methylation.
Top concepts
MedicineOncologyPathologyEngineeringEpigeneticsCell BiologyPharmacologyRadiotherapyTumor BiologyCancer Research
Publications per year
2004–2006
Enhancement of <i>In vitro</i> and <i>In vivo</i> Tumor Cell Radiosensitivity by the DNA Methylation Inhibitor Zebularine
Hideaki Dote, David Cerna, William Burgan et al. · Clinical Cancer Research · 2005 · 108 citations · Full text
Engineering, Radiation Effect, Dna Methylation +19
Enhanced Tumor Cell Radiosensitivity and Abrogation of G2 and S Phase Arrest by the Hsp90 Inhibitor 17-(Dimethylaminoethylamino)-17-demethoxygeldanamycin
Elizabeth E.A. Bull, Hideaki Dote, Kristin J. Brady et al. · Clinical Cancer Research · 2004 · 95 citations · Full text
Inhibition of Akt by the alkylphospholipid perifosine does not enhance the radiosensitivity of human glioma cells
Lorena de la Peña, William Burgan, Donna J. Carter et al. · Molecular Cancer Therapeutics · 2006 · 45 citations · Full text
<i>In vitro</i> and <i>In vivo</i> Radiosensitization Induced by the Ribonucleotide Reductase Inhibitor Triapine (3-Aminopyridine-2-Carboxaldehyde-Thiosemicarbazone)
Christopher A. Barker, William Burgan, Donna J. Carter et al. · Clinical Cancer Research · 2006 · 36 citations
1–4 of 4